Shree Ganesh Remedies Ltd — Important, 23-01-2026: Company Update

Shree Ganesh Remedies reported its financial results for the quarter and nine months, with Q3FY26 revenue down 22% year-on-year to 21.11 Cr and PAT falling 43% to 3.10 Cr. The company attributed this to shipment delays, deferring 10-12% of topline to Q4FY26, challenging European demand, and increased competition affecting realizations. Management stated FY26 is a year of consolidation, maintaining a strong long-term outlook. Operationally, a new pilot facility is commissioned, and Block 7 expansion is on track for H1FY27. The company expects gradual business improvement in FY27 driven by new product development and CRAMS project growth.